Study findings support the use of a personalized medicine approach to treat Soft Tissue Sarcomas
Peer-Reviewed Publication
Updates every hour. Last Updated: 22-Jun-2025 16:10 ET (22-Jun-2025 20:10 GMT/UTC)
A study conducted by researchers from the Agency for Science, Technology and Research (A*STAR), National Cancer Centre Singapore (NCCS) and National University of Singapore (NUS), in collaboration with biotech company, KYAN Technologies, has demonstrated that a precision medicine approach improves treatment selection for patients with soft tissue sarcomas (STS) in a clinical setting. Published in npj Precision Oncology in March 2025, the study’s findings support using data-driven and phenotypic screening approaches to treat STS.
Children who grow up in disadvantaged neighborhoods – areas with higher levels of crime and deprivation, and lower access to community resources – are at risk of developing depression, and new research led by faculty at Binghamton University, State University of New York, may help to explain why.
Getting a timely diagnosis of autism spectrum disorder is a major challenge, but new research out of York University shows that how young adults, and potentially children, grasp objects could offer a simpler way to diagnose someone on the autism spectrum. The team, part of an international collaboration, used machine learning to analyze naturalistic hand movements – specifically, finger motions during grasping – in autistic and non-autistic individuals.
The TCT® Geoffrey O. Hartzler Master Operator Award will be presented to Kenneth Rosenfield, MD, MSc, during Transcatheter Cardiovascular Therapeutics® (TCT®), the annual scientific symposium of the Cardiovascular Research Foundation® (CRF®). TCT® will take place October 25-28, 2025, in San Francisco, California at the Moscone Center. The award is given each year to a physician who has advanced the field of interventional cardiovascular medicine through technical excellence and leadership.